Hossein Borghaei
Fox Chase Cancer Center(US)Temple University Health System(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics
Most-Cited Works
- → Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden(2018)3,112 cited
- → Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer(2019)2,788 cited
- → First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer(2017)2,556 cited
- → Sotorasib for Lung Cancers with KRAS p.G12C Mutation(2021)1,682 cited
- → Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study(2016)1,385 cited
- → Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer(2018)1,163 cited